Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the lisinopril market right now?

The growth in the market size of lisinopril has been impressive in the recent years. It is predicted to rise from $1.76 billion in 2024 to $1.88 billion in 2025, representing a compound annual growth rate (CAGR) of 6.7%. The expansion during the historical period is credited to a surge in accessibility, changes in lifestyle habits, increased implementation of screening programs, improved availability of generic lisinopril, and better patient compliance.

How fast Is the lisinopril market expected to grow, and what’s its future value?

The lisinopril market is anticipated to witness robust growth in the coming years, with a projection to reach $2.4 billion by 2029 growing at a compound annual growth rate of 6.3%. This predicted growth during the forecast period is due to factors such as increasing incidence of hypertension and heart diseases, availability of generic variants and their economic feasibility, advancing awareness and early diagnosis, increased requirement for successful therapies, and an ageing population. Notable developing trends within the forecast period encompass advancements in drug delivery systems, the necessity for superior, patient-focused drug delivery methods, the call for cost-efficient solutions, a growing need for effective heart failure treatments, and an increased demand for effective diabetic kidney disease treatments.

Get your lisinopril market report here!

https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

What are the leading drivers of growth in the lisinopril market?

The increase in cardiovascular diseases is projected to stimulate the lisinopril market’s progress. The term Cardiovascular diseases (CVDs) covers various disorders that impact the heart and blood vessels. The rise in cardiovascular diseases is due to several reasons, including population expansion and ageing, risk elements, and inefficient prevention and treatment strategies. Lisinopril supports the management of cardiovascular diseases mainly by reducing blood pressure and decreasing the burden on the heart and kidneys. It accomplishes this by preventing the production of angiotensin II, enhancing blood vessel dilation, cutting down blood volume, and safeguarding organs against damage. For instance, the Singapore Heart Foundation (SHF), a non-profit organization in Singapore, reported in May 2024 that there were 5,302 deaths from ischemic heart diseases, a minor surge from 5,290 deaths in 2022. Therefore, the rise in cardiovascular diseases fuels the growth of the lisinopril market. Moving forward, the expansion of the lisinopril market is anticipated to be driven by the growing prevalence of hypertension, also known as high blood pressure. Hypertension refers to a medical issue where the force exerted by the blood against artery walls is continuously too high. The upswing in hypertension cases is linked to factors such as unhealthy dietary habits, a lack of physical activity, an ageing society, and chronic stress. Lisinopril is a successful treatment for hypertension as it impedes the formation of angiotensin II, which allows blood vessels to relax, reduces blood volume, and decreases blood pressure. For example, the World Health Organisation, based in Switzerland reported in March 2023 that about 1.28 billion adults aged between 30-79 years globally were suffering from hypertension in 2023. Thus, the rising occurrence of hypertension promotes the growth of the lisinopril market.

What are the key segments defining the lisinopril market?

The lisinopril market covered in this report is segmented –

1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands

2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases

3) By Dosage: Tablet, Liquid, Other Dosages

4) By Population Type: Children, Adults

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Zestoretic: Different Dosage Forms, Generic Versions Of Zestoretic

2) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil

3) By Zestril: Different Dosage Forms, Generic Versions Of Zestril

4) By Other Brands: International Brand Variants, Combination Drug Formulations

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

Who are the key players steering the development of the lisinopril market?

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16465

Which regions are most influential in expanding the lisinopril market?

North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pre-Collision Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pre-collision-technology-global-market-report

Automotive Collision Repair Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-collision-repair-global-market-report

Anti-Collision Sensor Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-collision-sensor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: